Thynk Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 1

Professionals

  • Investments
  • 24

  • Portfolio
  • 8

  • Exits
  • 9

Exits

Thynk Capital General Information

Company Description

Founded in 2003, Thynk Capital is a venture capital firm based in San Diego, California. The firm prefers to invest in therapeutics, healthcare, and technology companies. The firm focuses on early-stage pharma and biotech developing treatments to Extend Healthy lifespans and address the major diseases of aging, including Alzheimer's, Dementia, Kidney Disease, Cancer, Diabetes, Frailty, and Rare Diseases.

Business Details

Website
www.thynkcapital.com
Year Founded
2003
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Corporate Office
  • San Diego, CA 92121
  • United States
+1 (858)

Thynk Capital Investments (24)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
microMend 07-Dec-2021 Later Stage VC Surgical Devices Generating Revenue
IVIVA 12-Mar-2021 Biotechnology Generating Revenue
Elicio Therapeutics 17-Feb-2021 Drug Discovery Generating Revenue
Repair Biotechnologies 01-Sep-2020 Drug Discovery Pre-Clinical Trials
Elevian 21-Jul-2020 Drug Discovery Out of Business
X-Vax 18-Jul-2019 Drug Discovery Generating Revenue
Viscient Biosciences 10-Jun-2019 Drug Discovery Generating Revenue
X4 Pharmaceuticals 21-Sep-2018 Drug Discovery Generating Revenue
Theragene Pharmaceuticals 13-Dec-2017 Later Stage VC Biotechnology Generating Revenue
WinSanTor 16-Nov-2017 Later Stage VC Drug Discovery Clinical Trials - Phase 3
You’re viewing 10 of 24 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Thynk Capital Exits (9)

Company Name Exit Date Exit Type Exit Size
Elevian 18-Sep-2026 Out of Business
Theragene Pharmaceuticals 01-Sep-2025
X-Vax 22-Nov-2023
IVIVA 01-Oct-2023
Elicio Therapeutics 01-Jun-2023
Fisker 29-Oct-2020
Lubris BioPharma 15-Mar-2017
VIGO Photonics 25-Nov-2014 IPO
X4 Pharmaceuticals Secondary Transaction - Open Market
To view Thynk Capital’s complete exits history, request access »

Thynk Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Thynk Capital FAQs

  • What is Thynk Capital?

    Founded in 2003, Thynk Capital is a venture capital firm based in San Diego, California.

  • When was Thynk Capital founded?

    Thynk Capital was founded in 2003.

  • Where is Thynk Capital headquartered?

    Thynk Capital is headquartered in San Diego, CA.

  • How many investments has Thynk Capital made?

    Thynk Capital has made 24 investments.

  • What has Thynk Capital invested in?

    Thynk Capital has made numerous investments in companies like microMend, IVIVA, and Elicio Therapeutics within the Surgical Devices, Biotechnology, and Drug Discovery industries.

  • What has Thynk Capital invested in recently?

    Thynk Capital's latest investment was on 07-Dec-2021 in microMend, a company within the Surgical Devices industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process